盘龙药业荣获证券之星ESG公司治理先锋奖

Core Viewpoint - Panlong Pharmaceutical has been awarded the "Corporate Governance Pioneer Award" for its effective performance in corporate governance, highlighting its commitment to ESG (Environmental, Social, and Governance) practices [1] Group 1: Corporate Governance - The company implements a responsibility governance system that exceeds compliance requirements, enhancing internal risk management to create sustainable value for shareholders and society [3] - Panlong Pharmaceutical integrates ESG strategies into its top-level design, establishing a management system that ensures the long-term development strategy is forward-looking and effectively implemented [3] - The governance structure is built around a clear division of responsibilities among the shareholders' meeting, board of directors, and supervisory board, ensuring efficient and stable operations [3] Group 2: Risk Management - The company has developed a comprehensive risk management system that identifies potential risks in R&D, production, marketing, and compliance, with targeted prevention strategies in place [4] - A risk warning mechanism and regular risk assessments are employed to achieve dynamic monitoring and closed-loop management of risks [4] Group 3: Environmental Responsibility - In response to national "dual carbon" policies, the company is actively developing a climate change governance system and implementing energy-saving measures across its operations [5] - Panlong Pharmaceutical is focused on researching green pharmaceutical technologies to drive energy efficiency and reduce emissions [6] Group 4: Social Responsibility - The company prioritizes employee rights and fosters a diverse and safe working environment, achieving a 100% training coverage rate for employees [6] - Panlong Pharmaceutical engages in various charitable activities, donating 1.32 million yuan in 2024 to support education, disaster relief, and rural revitalization efforts [6] Group 5: Future Outlook - The company aims to deepen its ESG practices by leveraging party leadership, governance foundations, and innovation to contribute to the development of the health industry and the construction of a healthy China [6]